ArticleJournal of the advanced practitioner in oncology

Mogamulizumab-kpkc: A Novel Therapy for the Treatment of Cutaneous T-Cell Lymphoma.

Sutton Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.